Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 32, Issue 1, 2001, Pages 144-148

  Manegold, C ^a   Hannoun, C ^a   Wywiol, A ^a   Dietrich, M ^a   Polywka, S ^a   Chiwakata, C B ^a   Gunther S ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS GENOME; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; MALE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 0035136225     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317535     Document Type: Article

References (25)

1. Hepatitis B virus reactivation or reinfection associated with HIV infection
2. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS
3. Severe hepatitis in three AIDS patients treated with indinavir
4. Severe hepatitis in a HIV-positive subject under treatment with protease inhibitor
5. Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy
6. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor
7. Resolution of chronic hepatitis B after ritonavir treatment in an HIV-infected patient
8. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine
9. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal
10. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients
11. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: Frequency and functional consequences of PCR-introduced mutations
12. Hepatitis B virus immunopathogenesis
13. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
14. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
15. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
16. Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns
17. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group
18. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
19. Characterization of the reactivity pattern of murine monodonal antibodies against wild-type hepatitis B surface antigen to G145R and other natura]]y occurring "a" loop escape mutations
20. Vaccine-induced escape mutant of hepatitis B virus
21. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
22. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library
23. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy
24. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses
25. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy